Inventor · disambiguated record
Jan Egebjerg
Also filed as: EGEBJERG JAN
8 granted patents·3 pending applications·17 citations·filing 2016–2025
83Inventor score
Top patents by PatentIndex Score
11 records- 0192US10479835B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2016·Granted Nov 19, 2019·4 cites·16 claims
- 0292US10428147B2Anti-sortilin antibodies, uses and methods for treatmentH LUNDBECK AS·Filed 2016·Granted Oct 1, 2019·4 cites·7 claims
- 0390US10995141B2Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative diseaseIMMUNOBRAIN CHECKPOINT INC·Filed 2020·Granted May 4, 2021·4 cites·19 claims
- 0490US10889650B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2019·Granted Jan 12, 2021·2 cites·19 claims
- 0588US11548950B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2020·Granted Jan 10, 2023·1 cites·19 claims
- 0684US12331123B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2022·Granted Jun 17, 2025·0 cites·22 claims
- 0782US10894833B2Agents, uses and methods for treatmentH LUNDBECK AS·Filed 2018·Granted Jan 19, 2021·2 cites·4 claims
- 0882US2025277040A1Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2025·Application pending·0 cites
- 0972US2024052038A1Modified anti-PD-L1 Antibody and Methods and Uses for Treating a Neurodegenerative DiseaseIMMUNOBRAIN CHECKPOINT INC·Filed 2023·Application pending·0 cites
- 1067US11732046B2Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative diseaseIMMUNOBRAIN CHECKPOINT INC·Filed 2021·Granted Aug 22, 2023·0 cites·19 claims
- 1160US2021292414A1Agents, uses and methods for treatmentH LUNDBECK AS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Egebjerg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →